NM_018076.5:c.1237C>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018076.5(ODAD2):​c.1237C>G​(p.Arg413Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R413Q) has been classified as Benign.

Frequency

Genomes: 𝑓 0.092 ( 402 hom., cov: 17)
Exomes 𝑓: 0.084 ( 1247 hom. )

Consequence

ODAD2
NM_018076.5 missense, splice_region

Scores

18
Splicing: ADA: 0.002123
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.594

Publications

3 publications found
Variant links:
Genes affected
ODAD2 (HGNC:25583): (outer dynein arm docking complex subunit 2) The protein encoded by this gene contains ten Armadillo repeat motifs (ARMs) and one HEAT repeat, and is thought to be involved in ciliary and flagellar movement. This protein has been shown to localize to the ciliary axonemes and at the ciliary base of respiratory cells. Studies indicate that mutations in this gene cause partial outer dynein arm (ODA) defects in respiratory cilia. The cilia of cells with mutations in this gene displayed either reduced ciliary beat frequency and amplitude, or, complete immotility. Some individuals with primary ciliary dyskensia (PCD) have been shown to have mutations in this gene. PCD is characterized by chronic airway disease and left/right body asymmetry defects. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
ODAD2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 23
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00283131).
BP6
Variant 10-27968924-G-C is Benign according to our data. Variant chr10-27968924-G-C is described in ClinVar as Benign. ClinVar VariationId is 241255.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.102 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD2NM_018076.5 linkc.1237C>G p.Arg413Gly missense_variant, splice_region_variant Exon 9 of 20 ENST00000305242.10 NP_060546.2 Q5T2S8-1A0A140VKF7B7Z7Y0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD2ENST00000305242.10 linkc.1237C>G p.Arg413Gly missense_variant, splice_region_variant Exon 9 of 20 1 NM_018076.5 ENSP00000306410.5 Q5T2S8-1

Frequencies

GnomAD3 genomes
AF:
0.0919
AC:
11945
AN:
130030
Hom.:
402
Cov.:
17
show subpopulations
Gnomad AFR
AF:
0.105
Gnomad AMI
AF:
0.130
Gnomad AMR
AF:
0.0965
Gnomad ASJ
AF:
0.0599
Gnomad EAS
AF:
0.0112
Gnomad SAS
AF:
0.0863
Gnomad FIN
AF:
0.0553
Gnomad MID
AF:
0.0646
Gnomad NFE
AF:
0.0968
Gnomad OTH
AF:
0.0881
GnomAD2 exomes
AF:
0.0813
AC:
6008
AN:
73864
AF XY:
0.0803
show subpopulations
Gnomad AFR exome
AF:
0.108
Gnomad AMR exome
AF:
0.112
Gnomad ASJ exome
AF:
0.0497
Gnomad EAS exome
AF:
0.00912
Gnomad FIN exome
AF:
0.0547
Gnomad NFE exome
AF:
0.0944
Gnomad OTH exome
AF:
0.0867
GnomAD4 exome
AF:
0.0838
AC:
39388
AN:
469766
Hom.:
1247
Cov.:
5
AF XY:
0.0839
AC XY:
20962
AN XY:
249756
show subpopulations
African (AFR)
AF:
0.104
AC:
1295
AN:
12472
American (AMR)
AF:
0.114
AC:
2463
AN:
21672
Ashkenazi Jewish (ASJ)
AF:
0.0539
AC:
732
AN:
13580
East Asian (EAS)
AF:
0.00825
AC:
251
AN:
30426
South Asian (SAS)
AF:
0.0858
AC:
3916
AN:
45646
European-Finnish (FIN)
AF:
0.0585
AC:
2452
AN:
41904
Middle Eastern (MID)
AF:
0.0584
AC:
110
AN:
1882
European-Non Finnish (NFE)
AF:
0.0942
AC:
26035
AN:
276318
Other (OTH)
AF:
0.0825
AC:
2134
AN:
25866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1436
2871
4307
5742
7178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0918
AC:
11952
AN:
130150
Hom.:
402
Cov.:
17
AF XY:
0.0887
AC XY:
5553
AN XY:
62622
show subpopulations
African (AFR)
AF:
0.105
AC:
3557
AN:
33840
American (AMR)
AF:
0.0966
AC:
1231
AN:
12742
Ashkenazi Jewish (ASJ)
AF:
0.0599
AC:
185
AN:
3088
East Asian (EAS)
AF:
0.0112
AC:
54
AN:
4812
South Asian (SAS)
AF:
0.0866
AC:
303
AN:
3500
European-Finnish (FIN)
AF:
0.0553
AC:
480
AN:
8684
Middle Eastern (MID)
AF:
0.0620
AC:
17
AN:
274
European-Non Finnish (NFE)
AF:
0.0967
AC:
5875
AN:
60726
Other (OTH)
AF:
0.0863
AC:
144
AN:
1668
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
400
799
1199
1598
1998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0394
Hom.:
28
ExAC
AF:
0.0407
AC:
3186

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Jun 22, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Primary ciliary dyskinesia 23 Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
12
DANN
Benign
0.42
DEOGEN2
Benign
0.0060
T;T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.095
N
LIST_S2
Benign
0.45
T;T
MetaRNN
Benign
0.0028
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L;.
PhyloP100
0.59
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.2
N;N
REVEL
Benign
0.024
Sift
Benign
0.11
T;T
Sift4G
Benign
0.13
T;D
Polyphen
0.089
B;.
Vest4
0.11
MPC
2.1
ClinPred
0.0014
T
GERP RS
2.0
Varity_R
0.058
gMVP
0.15
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0021
dbscSNV1_RF
Benign
0.032
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57067036; hg19: chr10-28257853; COSMIC: COSV53462756; API